Marginal note:Duty to publicize clinical trial information
3.3 The holder of an authorization referred to in section 3.1 shall ensure that prescribed information concerning the clinical trial is made public within the prescribed time and in the prescribed manner.
- 2019, c. 29, s. 166
Version in force since May 23, 2020